SHANK3 as a target to reduce hypertrophy and heart failure

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

We have identified a large protein in heart that functions to facilitate the heart's response to disease. The proposed studies will define how this protein mediates responses and whether we can successfully interfere with the process to limit disease progression.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $548,908.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

drug discovery | heart failure | hypertrophy | mitral valve insufficiency | signalling pathways